Shares of Edwards Lifesciences Corp. /zigman2/quotes/205745196/composite EW +1.52% slipped 0.93% to $128.34 Monday, on what proved to be an all-around favorable trading session for the stock market, with the S&P 500 Index /zigman2/quotes/210599714/realtime SPX +2.02% rising 0.64% to 4,796.56 and the Dow Jones Industrial Average /zigman2/quotes/210598065/realtime DJIA +1.34% rising 0.68% to 36,585.06. This was the stock's second consecutive day of losses. Edwards Lifesciences Corp. closed $3.39 below its 52-week high ($131.73), which the company achieved on December 30th.
The stock underperformed when compared to some of its competitors Monday, as Medtronic PLC /zigman2/quotes/206816578/composite MDT +2.36% rose 2.56% to $106.10, Boston Scientific Corp. /zigman2/quotes/203726728/composite BSX +3.77% rose 1.51% to $43.12, and ICU Medical Inc. /zigman2/quotes/208026181/composite ICUI +2.79% fell 0.40% to $236.40. Trading volume (1.8 M) remained 661,072 below its 50-day average volume of 2.4 M.